Oruka Therapeutics, Inc.
ORKA
$29.91
$2.087.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -109.24M | -107.59M | -105.26M | -91.34M | -- |
| Total Depreciation and Amortization | 73.50K | 64.50K | 45.50K | 29.50K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.37M | 21.64M | 18.63M | 15.57M | -- |
| Change in Net Operating Assets | -891.30K | -10.02M | 2.79M | 12.64M | -- |
| Cash from Operations | -89.69M | -95.91M | -83.80M | -63.09M | -- |
| Capital Expenditure | -181.20K | -253.20K | -219.20K | -206.20K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -434.51M | -312.16M | -317.05M | -359.93M | -- |
| Cash from Investing | -434.69M | -312.41M | -317.27M | -360.14M | -- |
| Total Debt Issued | 2.27M | 2.27M | 2.27M | 27.25M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 207.37M | 454.68M | 454.57M | 454.57M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 266.50K | 266.50K | 266.50K | 3.20M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 449.10K | 6.98M | 5.39M | 5.39M | -- |
| Cash from Financing | 210.36M | 464.19M | 462.50M | 490.41M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -314.02M | 55.87M | 61.43M | 67.17M | -- |